Circulation Journal Official Journal of the Japanese Circulation Society http://www. j-circ.or.jp positive correlation between chronic kidney disease (CKD) and cardiovascular disease (CVD) has been demonstrated, but the causative role of uremic toxin remains unclear. 1-3 A number of retention compounds act as uremic toxins, accumulating in the blood of CKD patient, and elevated circulating uremic toxins negatively affect biological function through induction of oxidative stress. The removal of uremic solutes, therefore, has the potential to prevent CVD. However, protein-bound retention solutes are insufficiently eliminated even by hemodialysis. 4-6 Indoxyl sulfate (IS) is a protein-bound uremic toxin metabolized in the liver from indole, a tryptophan metabolite that is formed by intestinal bacteria. Together with CKD progression, IS accumulates in the blood, which leads to cellular toxicity by inducing oxidative stress. 7
positive correlation between chronic kidney disease (CKD) and cardiovascular disease (CVD) has been demonstrated, but the causative role of uremic toxin remains unclear. 1-3 A number of retention compounds act as uremic toxins, accumulating in the blood of CKD patient, and elevated circulating uremic toxins negatively affect biological function through induction of oxidative stress. The removal of uremic solutes, therefore, has the potential to prevent CVD. However, protein-bound retention solutes are insufficiently eliminated even by hemodialysis. 4-6 Indoxyl sulfate (IS) is a protein-bound uremic toxin metabolized in the liver from indole, a tryptophan metabolite that is formed by intestinal bacteria. Together with CKD progression, IS accumulates in the blood, which leads to cellular toxicity by inducing oxidative stress. 7 In particular, recent studies have suggested that IS is associated with vascular damage by inducing vasoactive substances related to atherogenesis such as chemokines, cytokines or cell adhesion molecules. 8, 9 As a possible mechanism of the process, we previously demonstrated that IS mediates monocyte chemoattractant protein-1 (MCP-1) expression in human umbilical vein endothelial cells (HUVECs) by producing reactive oxygen species (ROS) through NADPH oxidase activation. 10 MCP-1 is a chemokine that is involved in early stage of atherosclerosis through the recruitment of monocytes from the blood stream to the subendothelial space. 11- 13 Moreover, others have shown that IS-induced vascular damage exhibits inflammatory effects in monocytes, vascular smooth muscle cells or cardiac myocytes. 9,14, 15 Those studies indicate that IS plays A Indoxyl Sulfate as a Vascular Toxin a critical role in the cardiorenal syndrome to accelerate atherosclerosis, and therefore, treatment against the pernicious effects of IS is desirable to prevent subsequent CVD events in CKD patients. 16 A key to preventing IS-induced vascular toxicity is to find its molecular target in the cardiovascular system. According to studies, organic anion transporters (OATs) play an essential role in IS-induced nephrotoxicity through OAT1 or OAT3 in proximal tubular cells, although the molecular mechanism of IS in vascular cells has not been fully elucidated. 17, 18 Recently, IS as well as other tryptophan metabolites, such as tryptamine and indole acid, were shown to be potent endogenous agonists for the aryl hydrocarbon receptor (AhR), which induces xenobiotic enzymes in human hepatocytes. 19, 20 AhR is a ligand-activated, basic helix-loop-helix/per-ARNT-Sim transcriptional factor activated by a variety of agonists. With the stimulation of potent agonists, AhR translocates into the nucleus and dimerizes with AhR nuclear translocator (ARNT). The AhR/ARNT complex then transactivates target genes through binding to dioxin response elements (DRE) in promoter regions. 21 Activation of AhR is associated with multiple physiological processes of xenobiotic metabolism, development of organs in fetal life and promoting cancer. 22, 23 Moreover, AhR activation has been shown to have an important role in the vascular inflammatory response and development of atherosclerosis. Of note, AhR activation by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) leads to promotion of atherosclerotic lesions and upregulation of MCP-1 expression in macrophages. 24 Regarding AhR activation as a key player in atherogenesis, we focused on the effect of IS on the AhR pathway in endothelial cells. The aim of this study was to determine whether IS activates the AhR signaling pathway and to clarify further the mechanism involved in IS-induced phenotypic modulation in HUVECs.
Methods

Reagents
Medium 199, endothelial cell growth supplement, IS, TCDD, α-nafthofravone (ANF), CH223191 and probenecid were purchased from Sigma-Aldrich (St Louis, MO, USA). Fetal bovine serum (FBS) was purchased from Biological Industries (Haemek, Israel).
Cell Culture
HUVECs were purchased from Dainippon Sumitomo Pharmacy (Osaka, Japan) and cultured in a type I collagen-coated plate (Asahi Glass Tokyo, Japan) at 37°C and 5% CO2 in medium 199 supplemented with 10% FBS, 10 mmol/L glutamine, 100 μg/ml heparin, 20 μg/ml endothelial growth factor, 100 μg/ml gentamicin, and 100 μg/ml amphotericin B. Cells were used for experiments between passages 4 and 7. To determine MCP-1 secretion, HUVECs were incubated with IS (500 μmol/L) for 24 h. The supernatants were collected, and the MCP-1 released into the culture medium was quantified by sandwich ELISA (R&D Systems, Minneapolis, MN, USA), according to the manufacturer's protocol.
RNA Extraction and Reverse Transcription (RT)-Polymerase
Chain Reaction (PCR) Analysis MCP-1, CYP1A1 and CYP1B1 mRNA expressions were studied using RT and comparative PCR. Total RNA was extracted from HUVECs using ISOGEN (Nippon Gene, Toyama, Japan). The total RNA isolated by this method was undegraded and free of protein and DNA contamination. The sequences of the sense and antisense primers used for amplification were: MCP-1: 5′-ACTGAAGCTCGATACTCTC-3′, 5′-CTTGGGTTGT-GGAGTGAG-3′; CYP1A1: 5′-TCTTTCTCTTCCTGGC-TATC-3′, 5′-CTGTCTCTTCCCTTCACTCT-3′; CYP1B1: 5′-AGCCTCAGCCCGAACGACCC-3′, 5′-GCACCAGCAGC-GCCACCAGC-3′; GAPDH: 5′-ACCACCTGGTGCTCAGT-GTA-3′, 5′-ACCATCTTCCAGGAGCGAGA-3′. Images were acquired in a ChemiDoc XRS System (Bio-Rad, CA, USA) and analyzed with PDQuest software (Bio-Rad). The results for the expression of specific mRNAs were always normalized to GAPDH, and expressed as fold increase over control.
Real-Time RT-PCR
NADPH oxidase 4 (Nox4) mRNA expression was analyzed with quantitative real-time RT-PCR using an iQ5 Real-Time PCR Detection System (Bio-Rad) and the iScript One-Step RT-PCR Kit with SYBR Green (Bio-Rad). The sequences of the sense and antisense primers used for amplification were: NOX4: 5′-CAGAAGGTTCCAAGCAGGAG-3′, 5′-GTT-GAGGGCATTCACCAGAT-3′ and GAPDH: GACCCCTT-GATTGACCTCAAC-3′, 5′-CTTCTCCATGGTGGTGAAGA-3′. The fluorescent signal from SYBR Green was detected immediately after the extension step and the threshold cycle (Ct) was recorded. The Ct value from GAPDH served as an internal control for normalization.
Collection of Nuclear Fractions and Western Blot Analysis
HUVECs were suspended in ice-cold phosphate-buffered saline (PBS), homogenized for 10 strokes using a glass Dounce homogenizer, and centrifuged (12,000 g, 30 s, 4°C). The pellet was collected and re-suspended in 200 μl of ice-cold buffer A [10 mmol/L HEPES-KOH (pH 7.9), 1.5 mmol/L MgCl2, 10 mmol/L KCl, 0.5 mmol/L dithiothreitol, 0.2 mmol/L PMSF, 5 μg/ml aprotinin, and 2 μg/ml leupeptin]. After incubation on ice for 10 min, 10 μl of 10% IGEPAL was added and the mixture was churned thoroughly for 30 s and centrifuged (12,000 g, 30 s, 4°C), and then the supernatant was collected as the cytosolic fraction. The nuclear pellet was re-suspended in 50 μl of ice-cold buffer B, which was prepared by adding NaCl (finally, 300 mmol/L), glycerol (finally, 25%) and EDTA (finally, 0.25 mmol/L) to buffer A. After incubation on ice for 20 min, the mixture was centrifuged (12,000 g, 20 min, 4°C), and then the supernatant was collected as the nuclear fraction. 8 A protein sample (10 μg) of each fraction was electrophoretically blotted to PVDF membranes in 7.5% SDS-PAGE, and then detected by Anti AhR antibody (R&D Systems), Anti β-actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or lamin A/C antibody (Cell Signaling Technology, Beverly, MA, USA). Images were acquired in a ChemiDoc XRS System (Bio-Rad) and analyzed with PDQuest software (BioRad). The results for the expression of specific proteins were always normalized to β-actin and the nuclear expression of AhR was particularly normalized to lamin A/C. Fold increase over control was determined respectively.
Production of Superoxide
HUVECs, which were cultured in glass-based dish (Asahi Technos Co Ltd, Tokyo, Japan), was washed with PBS and incubated in a covered humidification chamber with dihydroethidium (DHE: 10 μmol/L in PBS) for 30 min at 37°C, and then superoxide was detected as the red fluorescence of ethidium using the LSM510-V4.0 (Carl Zeiss Co Ltd, Germany).
Statistical Analysis
Results are expressed as mean values ± standard error of the mean (SEM). Comparisons among groups were performed by 226 WATANABE I et al. 
Results
IS-Induced MCP-1 Expression Abolished by AhR Inhibitors, But Not by Probenecid
In agreement with our previous study, exposure to 500 μmol/L IS for 24 h markedly increased MCP-1 expression (Figures 1A,  B) . 10 At first, we investigated the effect of probenecid, an OAT inhibitor, and as shown in Figures 1A and 1B 1A,B) . Further, to confirm AhR is involved in IS-mediated MCP-1 expression, we performed additional experiments to see if these AhR inhibitors regulate MCP-1 expression dose-dependently. As shown in Figure 1C and 1D, the inhibitors abolished MCP-1 expression in HUVECs in a dose-dependent manner.
AhR Activated With IS in HUVECs
Recently, IS has been identified as an AhR agonist in human hepatocytes, 19 but little is known about the physiological relevance of the interaction between IS and AhR to endothelial cell damage. To explore the role of AhR in IS-induced MCP-1 expression, we performed western blot analysis and RT-PCR. As shown in Figure 2A , 1 h incubation of HUVECs with 500 μmol/L IS markedly increased the mRNA expression of 2 representative AhR responsive genes, cytochromes P450 (CYP) 1A1 and 1B1, in a time-dependent manner. Moreover, induction of these genes at 1 h was canceled by AhR inhibitors in a similar pattern to 1 nmol/L TCDD ( Figure 2B ). To confirm that IS activates the AhR pathway, we performed western blot 
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analysis using the nuclear and cytosol fractions of IS-treated HUVECs. AhR expression in the nucleus was time-dependently increased with reduction of that in the cytoplasm, indicating translocation of AhR (Figures 2C,D) . Taken together, these observations indicate that IS serves as an agonist for AhR and activates the AhR pathway in HUVECs.
IS-Induced ROS Through AhR Activation
AhR activation by TCDD induces oxidative stress in various cell types, such as hepatocytes and bronchiolar cells, 25,26 which, in turn, causes tissue injury; however, little is known about endothelial cells. To examine if IS stimulates ROS production through AhR activation in HUVECs, resulting in endothelial damage, we initially investigated NADPH oxidase 4 (Nox4) expression by real-time RT-PCR. As shown in Figure 3A , IS significantly induced Nox4 gene expression in HUVECs, and pretreatment with ANF or CH223191 reversed IS-induced Nox4 expression to control levels. We next performed DHE staining to examine if enhanced Nox4 expression results in increased superoxide production in HUVECs. As is the case with TCDD, 1 h incubation of HUVECs with IS stimulated superoxide production and this change was inhibited by ANF or CH223191, in a similar pattern to Nox4 expression ( Figure 3B ).
IS-Mediated AhR Activation Stimulates MCP-1 Expression Through Oxidative Stress
We previously reported that increased oxidative stress by IS stimulates MCP-1 expression in HUVECs. 10 We thus speculated that AhR pathway-derived oxidative stress could mediate IS-dependent MCP-1 expression in HUVECs. Figure 4A and Figure 4B show that MCP-1 expression was significantly increased by IS as previously reported and that tempol reversed MCP-1 expression. Furthermore, the IS-induced increase in MCP-1 expression was clearly suppressed with ANF to a similar level as with tempol, indicating that the IS-activated AhR pathway stimulates ROS production, which in turn, induces MCP-1 expression in HUVECs.
Discussion
This is the first report to show that IS activates AhR in HUVECs and that AhR pathway-derived oxidative stress induces MCP-1 expression. Ligand-mediated AhR activity results in the formation of the AhR/ANRT heterodimer through AhR translocation into the nucleus from the cytoplasm, which enables DRE to induce phases I and II xenobiotic metabolism-related target gene expression. AhR activation regulates xenobiotic metabolism, endocrine function, carcinogenesis and immunity. 22,27,28 Two major categories of environmental compounds are known to activate AhR signaling: halogenate aromatic hydrocarbons such as TCDD and polycyclic aromatic hydrocarbons, such as benzo (a) pyrene. AhR activation by those agonists is involved in atherogenesis. 29-31 Notably, TCDD enhances cholesterol accumulation through AhR activation in U937 macrophages and enhances formation of atherosclerotic lesions in the aorta of the ApoE knockout mouse. 24 Benzo (a) pyrene also upregulates atherosclerotic plaque formation in the ApoE knock out mouse and induces MCP-1 expression in HUVECs through AhR activation. 31 Additionally, CYP1A1, which is induced by TCDD, promotes ROS generation in human aortic endothelial cells and decreases nitric oxide (NO) production, indicating that AhR activation induces endothelial dysfunction. 32 These studies suggest that ligand-activated AhR induces a response in cardiovascular cells, although there are other potential ago- 9 However, in our experimental setting, probenecid failed to prevent MCP-1 and Nox4 expressions in HUVECs with IS treatment. In the current study, we thus clearly demonstrated that AhR in endothelial cells plays a pivotal role in IS-induced MCP-1 expression with enhanced ROS production. However, some limitations still remain in our work. Because AhR is a ligand-activated transcriptional factor, we need to further examine how IS stimulates AhR and affects NADPH expression with enhanced ROS production. In addition, in healthy individuals, more than 90% of IS binds to serum albumin 40 and from its molecular structure the bound form of IS does not seem to activate AhR. However, with progression of renal dysfunction, albumin-binding capacity is reduced 41 and the serum level of the unbound form of IS is elevated in patients with CKD (unpublished data), which, in turn, may lead to development of CVD. Recently, evidence has accumulated that IS is associated with clinical outcome particularly in CVD, 42 and further investigation is required to demonstrate if the AhR pathway is activated in the vasculature of individuals with CKD.
In conclusion, we demonstrated for the first time that IS activates AhR in HUVECs and induces MCP-1 expression through oxidative stress. Our findings, therefore, give us new insights into AhR as a therapeutic target of cardiorenal syndrome. 
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